National Institute on Aging; Notice of Closed Meetings, 18388-18389 [E9-9276]
Download as PDF
<![CDATA[
18388
Federal Register / Vol. 74, No. 76 / Wednesday, April 22, 2009 / Notices
Send comments to Summer King,
SAMHSA Reports Clearance Officer,
Room 7–1044, One Choke Cherry Road,
Rockville, MD 20857 and e-mail her a
copy at summer.king@samhsa.hhs.gov.
Written comments should be received
within 60 days of this notice.
Dated: April 13, 2009.
Elaine Parry,
Director, Office of Program Services.
[FR Doc. E9–9193 Filed 4–21–09; 8:45 am]
BILLING CODE 4162–20–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Agency Information Collection
Activities: Proposed Collection;
Comment Request
In compliance with Section
3506(c)(2)(A) of the Paperwork
Reduction Act of 1995 concerning
opportunity for public comment on
proposed collections of information, the
Substance Abuse and Mental Health
Services Administration (SAMHSA)
will publish periodic summaries of
proposed projects. To request more
information on the proposed projects or
to obtain a copy of the information
collection plans, call the SAMHSA
Reports Clearance Officer on (240) 276–
1243.
Comments are invited on: (a) Whether
the proposed collections of information
are necessary for the proper
performance of the functions of the
agency, including whether the
information shall have practical utility;
(b) the accuracy of the agency’s estimate
of the burden of the proposed collection
of information; (c) ways to enhance the
quality, utility, and clarity of the
information to be collected; and (d)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques or
other forms of information technology.
Proposed Project: Mandatory
Guidelines for Federal Workplace Drug
Testing Programs (OMB No. 0930–
0158)—Extension
SAMHSA’s Mandatory Guidelines for
Federal Workplace Drug Testing
Programs will request OMB approval for
the Federal Drug Testing Custody and
Control Form for Federal agency and
federally regulated drug testing
programs which must comply with the
HHS Mandatory Guidelines for Federal
Workplace Drug Testing Programs (69
FR 19644) dated April 13, 2004, and for
the information provided by laboratories
for the National Laboratory Certification
Program (NLCP).
The Federal Drug Testing Custody
and Control Form is used by all Federal
agencies and employers regulated by the
Department of Transportation to
document the collection and chain of
custody of urine specimens at the
collection site, for laboratories to report
results, and for Medical Review Officers
to make a determination. The Federal
Drug Testing Custody and Control Form
approved by OMB three years ago is
being resubmitted for OMB approval
without any revision.
Prior to an inspection, a laboratory is
required to submit specific information
regarding its laboratory procedures.
Collecting this information prior to an
inspection allows the inspectors to
thoroughly review and understand the
laboratory’s testing procedures before
arriving at the laboratory.
The NLCP application form has not
been revised compared to the previous
form.
The annual total burden estimates for
the Federal Drug Testing Custody and
Control Form, the NLCP application, the
NLCP inspection checklist, and NLCP
recordkeeping requirements are shown
in the following table.
Burden/
response
(hrs.)
Form/respondent
Number of
responses
Total annual
burden
(hrs.)
Custody and Control Form:
Donor ....................................................................................................................................
Collector ................................................................................................................................
Laboratory .............................................................................................................................
Medical Review Officer .........................................................................................................
Laboratory Application .................................................................................................................
Laboratory Inspection Checklist ..................................................................................................
Laboratory Recordkeeping ..........................................................................................................
.08
.07
.05
.05
3.00
3.00
250.00
7,096,000
7,096,000
7,096,000
7,096,000
3
100
50
567,680
496,720
354,800
354,800
9
300
12,500
Total ......................................................................................................................................
........................
........................
1,786,809
dwashington3 on PROD1PC60 with NOTICES
Send comments to Summer King,
SAMHSA Reports Clearance Officer,
Room 7–1044, One Choke Cherry Road,
Rockville, MD 20857 and e-mail her a
copy at summer.king@samhsa.hhs.gov.
Written comments should be received
within 60 days of this notice.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: April 13, 2009.
Elaine Parry,
Director, Office of Program Services.
[FR Doc. E9–9187 Filed 4–21–09; 8:45 am]
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
BILLING CODE 4162–20–P
VerDate Nov<24>2008
15:31 Apr 21, 2009
Jkt 217001
National Institutes of Health
National Institute on Aging; Notice of
Closed Meetings
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel, Nutrition and
Aging of Brain.
Date: June 9, 2009.
Time: 11 a.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
National Institutes of Health, Gateway
Building, Room 2C/212, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Alexander Parsadanian,
PhD, Scientific Review Officer, National
E:\FR\FM\22APN1.SGM
22APN1
Federal Register / Vol. 74, No. 76 / Wednesday, April 22, 2009 / Notices
Institute on Aging, Gateway Building 2C/212,
7201 Wisconsin Avenue, Bethesda, MD
20892, 301–402–7703,
parsadaniana@nia.nih.gov.
Name of Committee: National Institute on
Aging Special Emphasis Panel, Aging and
Economics.
Date: June 17, 2009.
Time: 11 a.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
National Institutes of Health, Gateway
Building, Room 2C/212, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Rebecca J. Ferrell, PhD,
Scientific Review Officer, National Institute
on Aging, Gateway Building 2C212, 7201
Wisconsin Avenue, Bethesda, MD 20814,
301–402–7703, ferrellrj@mail.nih.gov.
Name of Committee: National Institute on
Aging Special Emphasis Panel,
Mitochondrial Antioxidants and Aging.
Date: June 19, 2009.
Time: 11 a.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
National Institutes of Health, Gateway
Building, Room 2C/212, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Alexander Parsadanian,
PhD, Scientific Review Officer, National
Institute on Aging, Gateway Building 2C/212,
7201 Wisconsin Avenue, Bethesda, MD
20892, 301–402–7703,
parsadaniana@nia.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
Dated: April 16, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–9276 Filed 4–21–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
dwashington3 on PROD1PC60 with NOTICES
National Institute of Neurological
Disorders and Stroke; Notice of
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
National Advisory Neurological
Disorders and Stroke Council.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
VerDate Nov<24>2008
15:31 Apr 21, 2009
Jkt 217001
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Neurological Disorders and Stroke Council.
Date: May 28–29, 2009.
Open: May 28, 2009, 10:30 a.m. to 4:45
p.m.
Agenda: Report by the Director, NINDS;
Report by the Associate Director for
Extramural Research; Other Administrative
and Program Developments; and an
Overview of the NINDS Intramural Program.
Place: National Institutes of Health,
Building 31, 31 Center Drive, C Wing,
Conference Room 10, Bethesda, MD 20892.
Closed: May 28, 2009, 4:45 p.m. to 5:15
p.m.
Agenda: To review and evaluate the
Division of Intramural Research Board of
Scientific Counselors’ Reports.
Place: National Institutes of Health,
Building 31, 31 Center Drive, C Wing,
Conference Room 10, Bethesda, MD 20892.
Closed: May 29, 2009, 8 a.m. to 12 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Building 31, 31 Center Drive, C Wing,
Conference Room 10, Bethesda, MD 20892.
Contact Person: Robert Finkelstein, Ph.D.,
Associate Director for Extramural Research,
National Institute of Neurological, Disorders
and Stroke, NIH, 6001 Executive Blvd., Suite
3309, MSC 9531, Bethesda, MD 20892, (301)
496–9248.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Information is also available on the
Institute’s/Center’s home page: https://
www.ninds.nih.gov, where an agenda and
any additional information for the meeting
will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS)
PO 00000
Frm 00042
Fmt 4703
Sfmt 4703
18389
Dated: April 16, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–9225 Filed 4–21–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
National Advisory Neurological
Disorders and Stroke Council.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Neurological Disorders and Stroke Council,
Clinical Trials Subcommittee.
Date: May 27–28, 2009.
Closed: May 27, 2009, 6 p.m. to 7:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Open: May 28, 2009, 8 a.m. to 10 a.m.
Agenda: To discuss clinical trials policy.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 10, Bethesda, MD 20892.
Contact Person: Deborah G Hirtz, MD,
Acting Director, Clinical Trials Cluster,
National Institute of Neurological Disorders
and Stroke, National Institute of Health, 6001
Executive Blvd., Suite 2212, Bethesda, MD
20892. (301) 496–5821. hirtz@ninds.nih.gov.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
E:\FR\FM\22APN1.SGM
22APN1
]]>Agencies
[Federal Register Volume 74, Number 76 (Wednesday, April 22, 2009)]
[Notices]
[Pages 18388-18389]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-9276]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute on Aging Special Emphasis
Panel, Nutrition and Aging of Brain.
Date: June 9, 2009.
Time: 11 a.m. to 4 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute on Aging, National Institutes of
Health, Gateway Building, Room 2C/212, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Alexander Parsadanian, PhD, Scientific Review
Officer, National
[[Page 18389]]
Institute on Aging, Gateway Building 2C/212, 7201 Wisconsin Avenue,
Bethesda, MD 20892, 301-402-7703, parsadaniana@nia.nih.gov.
Name of Committee: National Institute on Aging Special Emphasis
Panel, Aging and Economics.
Date: June 17, 2009.
Time: 11 a.m. to 4 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute on Aging, National Institutes of
Health, Gateway Building, Room 2C/212, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Rebecca J. Ferrell, PhD, Scientific Review
Officer, National Institute on Aging, Gateway Building 2C212, 7201
Wisconsin Avenue, Bethesda, MD 20814, 301-402-7703,
ferrellrj@mail.nih.gov.
Name of Committee: National Institute on Aging Special Emphasis
Panel, Mitochondrial Antioxidants and Aging.
Date: June 19, 2009.
Time: 11 a.m. to 4 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute on Aging, National Institutes of
Health, Gateway Building, Room 2C/212, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Alexander Parsadanian, PhD, Scientific Review
Officer, National Institute on Aging, Gateway Building 2C/212, 7201
Wisconsin Avenue, Bethesda, MD 20892, 301-402-7703,
parsadaniana@nia.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.866, Aging
Research, National Institutes of Health, HHS)
Dated: April 16, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-9276 Filed 4-21-09; 8:45 am]
BILLING CODE 4140-01-P
